Disclosed is a compound of Formula I or a salt thereof, in which X, X1, X2, R1, R2, and R3 are described herein. Also disclosed are pharmaceutical compositions and methods of using the compounds of Formula I to treat disorders mediated by melanocortin-4 receptors.
本文披露了一种公式I的化合物或其盐,其中X、X1、X2、R1、R2和R3如本文所述。还披露了利用公式I的化合物治疗由
黑色素皮质素-4受体介导的疾病的药物组合物和方法。